BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 22351760)

  • 1. Cross-talk between integrin α6β4 and insulin-like growth factor-1 receptor (IGF1R) through direct α6β4 binding to IGF1 and subsequent α6β4-IGF1-IGF1R ternary complex formation in anchorage-independent conditions.
    Fujita M; Ieguchi K; Davari P; Yamaji S; Taniguchi Y; Sekiguchi K; Takada YK; Takada Y
    J Biol Chem; 2012 Apr; 287(15):12491-500. PubMed ID: 22351760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor (IGF) signaling requires αvβ3-IGF1-IGF type 1 receptor (IGF1R) ternary complex formation in anchorage independence, and the complex formation does not require IGF1R and Src activation.
    Fujita M; Takada YK; Takada Y
    J Biol Chem; 2013 Feb; 288(5):3059-69. PubMed ID: 23243309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An integrin binding-defective mutant of insulin-like growth factor-1 (R36E/R37E IGF1) acts as a dominant-negative antagonist of the IGF1 receptor (IGF1R) and suppresses tumorigenesis but still binds to IGF1R.
    Fujita M; Ieguchi K; Cedano-Prieto DM; Fong A; Wilkerson C; Chen JQ; Wu M; Lo SH; Cheung AT; Wilson MD; Cardiff RD; Borowsky AD; Takada YK; Takada Y
    J Biol Chem; 2013 Jul; 288(27):19593-603. PubMed ID: 23696648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct integrin binding to insulin-like growth factor-2 through the C-domain is required for insulin-like growth factor receptor type 1 (IGF1R) signaling.
    Cedano Prieto DM; Cheng Y; Chang CC; Yu J; Takada YK; Takada Y
    PLoS One; 2017; 12(9):e0184285. PubMed ID: 28873464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The direct binding of insulin-like growth factor-1 (IGF-1) to integrin alphavbeta3 is involved in IGF-1 signaling.
    Saegusa J; Yamaji S; Ieguchi K; Wu CY; Lam KS; Liu FT; Takada YK; Takada Y
    J Biol Chem; 2009 Sep; 284(36):24106-14. PubMed ID: 19578119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crosstalk between insulin-like growth factor (IGF) receptor and integrins through direct integrin binding to IGF1.
    Takada Y; Takada YK; Fujita M
    Cytokine Growth Factor Rev; 2017 Apr; 34():67-72. PubMed ID: 28190785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of Ligand and Shear Stress-induced Insulin-like Growth Factor 1 (IGF1) Signaling by the Integrin Pathway.
    Tahimic CG; Long RK; Kubota T; Sun MY; Elalieh H; Fong C; Menendez AT; Wang Y; Vilardaga JP; Bikle DD
    J Biol Chem; 2016 Apr; 291(15):8140-9. PubMed ID: 26865633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct binding of the EGF-like domain of neuregulin-1 to integrins ({alpha}v{beta}3 and {alpha}6{beta}4) is involved in neuregulin-1/ErbB signaling.
    Ieguchi K; Fujita M; Ma Z; Davari P; Taniguchi Y; Sekiguchi K; Wang B; Takada YK; Takada Y
    J Biol Chem; 2010 Oct; 285(41):31388-98. PubMed ID: 20682778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoplasmic domain interactions of syndecan-1 and syndecan-4 with α6β4 integrin mediate human epidermal growth factor receptor (HER1 and HER2)-dependent motility and survival.
    Wang H; Jin H; Beauvais DM; Rapraeger AC
    J Biol Chem; 2014 Oct; 289(44):30318-30332. PubMed ID: 25202019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the quantitative balance between insulin-like growth factor (IGF)-1 ligand, receptor, and binding protein levels to predict cell sensitivity and therapeutic efficacy.
    Tian D; Kreeger PK
    BMC Syst Biol; 2014 Aug; 8():98. PubMed ID: 25115504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor 1 increases apical fibronectin in blastocysts to increase blastocyst attachment to endometrial epithelial cells in vitro.
    Green CJ; Fraser ST; Day ML
    Hum Reprod; 2015 Feb; 30(2):284-98. PubMed ID: 25432925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synstatin: a selective inhibitor of the syndecan-1-coupled IGF1R-αvβ3 integrin complex in tumorigenesis and angiogenesis.
    Rapraeger AC
    FEBS J; 2013 May; 280(10):2207-15. PubMed ID: 23375101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-β-induced expression of IGFBP-3 regulates IGF1R signaling in human osteosarcoma cells.
    Schedlich LJ; Yenson VM; Baxter RC
    Mol Cell Endocrinol; 2013 Sep; 377(1-2):56-64. PubMed ID: 23831640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial-cadherin stimulates syndecan-1-coupled insulin-like growth factor-1 receptor and cross-talk between αVβ3 integrin and vascular endothelial growth factor receptor 2 at the onset of endothelial cell dissemination during angiogenesis.
    Rapraeger AC; Ell BJ; Roy M; Li X; Morrison OR; Thomas GM; Beauvais DM
    FEBS J; 2013 May; 280(10):2194-206. PubMed ID: 23331867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis of the interaction between integrin alpha6beta4 and plectin at the hemidesmosomes.
    de Pereda JM; Lillo MP; Sonnenberg A
    EMBO J; 2009 Apr; 28(8):1180-90. PubMed ID: 19242489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrins αvβ3 and α4β1 act as coreceptors for fractalkine, and the integrin-binding defective mutant of fractalkine is an antagonist of CX3CR1.
    Fujita M; Takada YK; Takada Y
    J Immunol; 2012 Dec; 189(12):5809-19. PubMed ID: 23125415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGF1R blockade with ganitumab results in systemic effects on the GH-IGF axis in mice.
    Moody G; Beltran PJ; Mitchell P; Cajulis E; Chung YA; Hwang D; Kendall R; Radinsky R; Cohen P; Calzone FJ
    J Endocrinol; 2014 Apr; 221(1):145-55. PubMed ID: 24492468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral pain is enhanced by insulin-like growth factor 1 and its receptors in a mouse model of type 2 diabetes mellitus.
    Tang Z; Cao F; Zhang H; Tang J; Li H; Zhang Y; Feng B; Wang H
    J Diabetes; 2019 Apr; 11(4):309-315. PubMed ID: 30105862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor 1 signaling in tenocytes is required for adult tendon growth.
    Disser NP; Sugg KB; Talarek JR; Sarver DC; Rourke BJ; Mendias CL
    FASEB J; 2019 Nov; 33(11):12680-12695. PubMed ID: 31536390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LMP1 promotes expression of insulin-like growth factor 1 (IGF1) to selectively activate IGF1 receptor and drive cell proliferation.
    Tworkoski K; Raab-Traub N
    J Virol; 2015 Mar; 89(5):2590-602. PubMed ID: 25520502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.